Get started

LALPATHLAB

Dr. Lal Path Lab Strong Bullish Momentum, Eyeing ₹3600On the weekly chart, Dr. Lal Path Lab stock is exhibiting a strong bullish trend, with solid upward momentum pushing the stock higher. Based on multiple RSI indicators, the stock remains above 60, signaling continued strength in the trend and positive buying pressure. Key Technical Insights: The stock is currently in a bullish phase and has broken key resistance levels, suggesting that it could continue its upward movement. ₹3249 is a major support level, providing a cushion for any potential short-term corrections and helping maintain the bullish bias. Considering all technical indicators, the stock stands out as an excellent candidate for swing trading, with an expected target of ₹3600 during the October expiry. Market Sentiment: While the technical outlook for Dr. Lal Path Lab is highly favorable, a few external market factors could impact its trajectory: Ongoing Middle East tensions may create volatility in global markets, including India. FII outflows from the Indian stock market add an element of risk, as foreign investors are pulling back due to global uncertainties. Conclusion: Dr. Lal Path Lab presents a strong swing trading opportunity, with a target of ₹3600 in October. Despite broader market risks like geopolitical concerns and foreign investor outflows, the stock’s technical strength makes it a promising pick in the current environment. Disclaimer: This is for educational purposes only and not financial advice. Please do your own research before making any investment decisions.
NSE:LALPATHLABLong
by Sudhir-Sirohi
Future of Dr Lal Pathlabs Ltd.Dr. Lal PathLabs Limited is one of Bharat’s leading consumer healthcare brand in diagnostic services. The share price is currently 42% down from its lifetime high. It is constantly earning profit and has reduced its debt in the past few years. the company is also maintaining a healthy dividend yield. Promoter has not pledged their shares. So it is a good buy currently as the whole market is at a premium valuation and such gems are hard to find which are 42% down from lifetime high. Good for Investment purpose. Note- Do your own analysis before investing
NSE:LALPATHLABLong
by ronak16125
LALPATHLAB - Stock AnalysisDr. Lal Pathlabs Ltd. presents a mixed technical and fundamental profile, with some bullish and bearish signals, making it an interesting company for investors to watch. From a technical perspective, the HighLow indicator is "Strong Bullish," suggesting that the stock is near a one-year high and likely to make a new high. The one-day analysis is "Bullish," with the latest tick showing a strong price rise, though caution is advised to keep an eye on the volume. The Parabolic SAR (PSAR) is "Bullish" with a bullish crossover, while the HighLowMABand indicates "Strong Bullish" sentiment with a positive breakout pattern. However, the MACD (Moving Average Convergence Divergence) is "Strong Bearish," as it has experienced a bearish crossover with the signal line and a zero-line crossover. Additionally, there are indications of MACD Divergence at long-term top price points on October 16, 2023, and July 27, 2023. The Supertrend is "Strong Bearish," trending downwards. On the positive side, daily candlestick patterns and chart patterns, including Long-Term and Medium-Term Ascending Triangles, are "Strong Bullish," providing some technical support. From a fundamental perspective, Dr. Lal Pathlabs Ltd. has notable strengths. The company has shown tremendous growth in its Book Value over the last three years and has an impressive Piotroski F Score of 8.0, indicating excellent financial health. There's also excellent quarter-over-quarter (QoQ) FY EPS growth, and the company is earning an excess return. Furthermore, the company's Net Profit has been consistently increasing for the last five quarters, and the same goes for Profit Before Tax, indicating strong operational performance. There has been steady growth in EPS over the last four quarters. The company also maintains a good Return On Capital Employed of 12.67% and a solid Return on Equity of 16.61%. Additionally, it boasts a good Net Margin of 12.84%. However, Dr. Lal Pathlabs Ltd. offers a very low dividend yield of 0.760%, suggesting a preference for reinvesting profits for growth. On the sales and asset side, there is a positive trend, with quarterly sales over the last five years showing an upward trajectory and a steady increase in Total Assets over the last three years, reflecting the company's consistent growth and financial stability. In conclusion, Dr. Lal Pathlabs Ltd. presents a complex profile, with some bullish technical indicators but significant bearish signals. However, the company's strong fundamentals, including solid financial health and consistent growth in various aspects, make it an intriguing investment option. Investors should closely monitor both technical and fundamental developments for a comprehensive understanding of the stock's potential. Go Long above 2479.95/2499 Stop Loss 2287
NSE:LALPATHLABLong
by ruelfernandes
LALPATHLAB : Weekly SupportLALPATHLAB is trading near weekly FLIP support zone, it is major support zone for any charts. 1865 is good level for expecting change the trend and good entry point with best R:R. Do you analysis before entering any trade. Like, Share, Comment for regular updates. Disclaimer I am not sebi registered analyst My studies are Educational purpose only Please consult with your Financial advisor before trading or investing I may be 100% wrong as its my personal trade. First Learn and then remove "L"
NSE:LALPATHLAB
by ChartsSpecialist
#LALPATHLAB #MOREPENLAB #IPCALAB #DIVISLAB #VIMTALAB #LAURUSLABS#LALPATHLAB NSE: LALPATHLAB CMP: 2345 TP: 3075 SL: 2100 TF: <6m RR > ~3 times Return > 30% THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming.
NSE:LALPATHLABLong
by Rachit_Sethia
#vimtalabs #ipcalab #lauruslabs #lalpathlab #guficbio #alkem#VIMTALABS NSE: VIMTALABS CMP: 461 TP: 560 SL: 410 TF: <6m RR > 2 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
NSE:VIMTALABSLong
by Rachit_Sethia
LALPATHLAB - MY STUDY 📊 Script: LALPATHLAB 📊 Nifty50 Stock: NO 📊 Sector: Health Service, Medical/Nursing Services. This stock pick is according to my study. I have use 4 indicator that is BOLLINGER BAND MACD RSI DOUBLE MOVING AVERAGE 📈 Stock is trading at upper band of BB. 📈 There is MACD crossover. 📈 RSI is around 66. 📈 There is crossover of double moving average. 🟢 Target 🎯🏆 - 2450 ⚠️ Stoploss ☠️🚫 - 2216 ⚠️ Important: Always maintain your Risk & Reward Ratio. ✅Like and follow to never miss a new idea!✅ Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
NSE:LALPATHLABLong
by radha_23
LALPATHLABThis stock has recently formed a double top pattern, which is a bearish sign, and also near mediun of depth of same pattern, so if it brokes 3600 levels than we can say that another doors have been opened towards south direction, or we can say towards previous swing lows near 3312. One can go short only below 3600 levels with stop loss of hourly closing above 3642. All the key levels are mentioned in chart with Stop-loss and Targets. Key Levels are Mentioned on chart Overall scenarios Macd in daily negative crossover Macd in hourly negative crossover Rsi in hourly below 40 Disclaimer I am not sebi registered analyst My studies are Educational purpose only Consult with your Financial advisor before trading or investing
NSE:LALPATHLABShort
by RK_Chaarts